Sinomab Bioscience Limited (3681)
Market Closed
13 Aug, 08:00
HKEX HKEX Primary 
XFRA 1. 20
HKD -0.01
-1.2397%
2.12B Market Cap
- P/E Ratio
- Div Yield
1.46M Volume
- Eps
1.21 HKD
Previous Close Want to track 3681 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sinomab Bioscience Limited (3681) Statistics
Valuation metrics
Market Cap 2.12B
Enterprise value 1.59B
Trailing P/E (ttm) -13.54
Forward P/E -
PEG ratio -0.2
Price/Sales (ttm) 161.79
Price/Book (mrq) 3.1
Enterprise Value/Revenue 162.3
Enterprise Value/EBITDA -13.3
Overview
Shares outstanding 1.39B
Float 896.34M
Shares short -
% Held by insiders 0.27%
% Held by institutions 0.09%
Average volume (10 days) 2.24M
Average volume (90 days) 2.93M
Price summary
52-Week low 0.99
52-Week high 3.63
Beta 0.66
50-Day moving average 1.18
200-Day moving average 1.47
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -10.64%
Operating margin -12.96%
Operational effectiveness
Return on assets -0.11%
Return on equity -0.28%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -131.86M
Net income to common (ttm) -120.77M
Diluted EPS (ttm) -0.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 433.97M
Total cash per share (mrq) 0.28
Total debt (mrq) 389.38M
Total Debt/Equity (mrq) 0.67
Current ratio (mrq) 1.91%
Book value per share (mrq) 0.37
Cash Flow
Cash flow statement -81.07M
Levered free cash flow (LFCF) -32.84M
